Surface plasmon resonance biosensors as a tool in antibody engineering.

Modern gene technology combined with efficient microbial expression systems provides tools to produce antibodies with reduced functional size and improved binding properties as well as antibody fusions or novel antibodies. Surface plasmon resonance based biosensors, which measure antigen-antibody interactions in real-time, can be used for a diverse characterization of the modified antibodies. To date, the majority of published work originates from real-time biospecific interaction analysis based on the BIAcore instruments. This article describes the range of applications in antibody engineering in which BIAcore has been applied.

[1]  K. Keinänen,et al.  Use of genetically engineered lipid-tagged antibody to generate functional europium chelate-loaded liposomes. Application in fluoroimmunoassay. , 1995, Journal of immunological methods.

[2]  A. Plückthun,et al.  Tetravalent miniantibodies with high avidity assembling in Escherichia coli. , 1995, Journal of molecular biology.

[3]  A. Plückthun,et al.  Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.

[4]  Y. Kurosawa,et al.  Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A. , 1993, The Journal of biological chemistry.

[5]  D G Myszka,et al.  Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. , 1997, Methods in enzymology.

[6]  M. V. Van Regenmortel,et al.  Concentration measurement of unpurified proteins using biosensor technology under conditions of partial mass transport limitation. , 1997, Analytical biochemistry.

[7]  R. R. Robinson,et al.  Escherichia coli secretion of an active chimeric antibody fragment. , 1988, Science.

[8]  G. Winter,et al.  Engineering bispecific antibodies. , 1993, Current opinion in biotechnology.

[9]  Brad Snedecor,et al.  High Level Escherichia coli Expression and Production of a Bivalent Humanized Antibody Fragment , 1992, Bio/Technology.

[10]  T. Teeri,et al.  An active single-chain antibody containing a cellulase linker domain is secreted by Escherichia coli. , 1991, Protein engineering.

[11]  W. P. Bennekom,et al.  Liposomes and immunoassays. , 1997, Journal of immunological methods.

[12]  Tristan J. Vaughan,et al.  Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library , 1996, Nature Biotechnology.

[13]  A. Plückthun,et al.  Expression of functional antibody Fv and Fab fragments in Escherichia coli. , 1989, Methods in enzymology.

[14]  C. MacKenzie,et al.  Analysis by Surface Plasmon Resonance of the Influence of Valence on the Ligand Binding Affinity and Kinetics of an Anti-carbohydrate Antibody (*) , 1996, The Journal of Biological Chemistry.

[15]  K A Chester,et al.  Clinical issues in antibody design. , 1995, Trends in biotechnology.

[16]  G. Winter,et al.  Making antibodies by phage display technology. , 1994, Annual review of immunology.

[17]  K. D. Hardman,et al.  Single-chain antigen-binding proteins. , 1988, Science.

[18]  R. Williams,et al.  Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody. , 1996, Protein engineering.

[19]  A Roberts,et al.  In vitro selection of a high affinity antibody to oestradiol using a phage display human antibody library. , 1996, Immunotechnology : an international journal of immunological engineering.

[20]  S. Durham,et al.  Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis , 1995, Nature Medicine.

[21]  R. Holmdahl,et al.  Binding of autoreactive mouse anti-type II collagen antibodies derived from the primary and the secondary immune response investigated with the biosensor technique. , 1995, Journal of immunological methods.

[22]  I. Pastan,et al.  Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  I. Pastan,et al.  Engineering antibody Fv fragments for cancer detection and therapy: Bisulfide-stabilized Fv fragments , 1996, Nature Biotechnology.

[24]  K. Keinänen,et al.  Functional immunoliposomes harboring a biosynthetically lipid-tagged single-chain antibody. , 1994, Biochemistry.

[25]  S. Songsivilai,et al.  Bispecific antibody: a tool for diagnosis and treatment of disease , 1990, Clinical and experimental immunology.

[26]  G. Winter,et al.  An Antibody Fragment from a Phage Display Library Competes for Ligand Binding to the Low Density Lipoprotein Receptor Family and Inhibits Rhinovirus Infection (*) , 1995, The Journal of Biological Chemistry.

[27]  Bo Johnsson,et al.  A novel hydrogel matrix on gold surfaces in surface plasmon resonance sensors for fast and efficient covalent immobilization of ligands , 1990 .

[28]  M. Whitlow,et al.  Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv. , 1994, Protein engineering.

[29]  D R Burton,et al.  A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Bruccoleri,et al.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Winter,et al.  Building Antibodies from their Genes , 1992, Immunological reviews.

[32]  T Prospero,et al.  "Diabodies": small bivalent and bispecific antibody fragments. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Liedberg,et al.  Surface plasmon resonance for gas detection and biosensing , 1983 .

[34]  Andrew D. Griffiths,et al.  By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling , 1992, Bio/Technology.

[35]  A. Chaffotte,et al.  Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. , 1985, Journal of immunological methods.

[36]  G. Adams,et al.  Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. , 1996, Journal of molecular biology.

[37]  E. Lasonder,et al.  A fast and sensitive method for the evaluation of binding of phage clones selected from a surface displayed library. , 1994, Nucleic Acids Research.

[38]  G. Winter,et al.  Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.

[39]  C. Borrebaeck,et al.  Selection of phage displayed antibodies based on kinetic constants. , 1996, Molecular immunology.

[40]  G. Winter,et al.  High-affinity antigen binding by chelating recombinant antibodies (CRAbs). , 1995, Journal of molecular biology.

[41]  R. Glockshuber,et al.  A comparison of strategies to stabilize immunoglobulin Fv-fragments. , 1990, Biochemistry.

[42]  I. Brooks,et al.  Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. , 1993, Analytical biochemistry.

[43]  I. Tomlinson,et al.  Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents. , 1994, The EMBO journal.

[44]  R W Glaser,et al.  Antigen-antibody binding and mass transport by convection and diffusion to a surface: a two-dimensional computer model of binding and dissociation kinetics. , 1993, Analytical biochemistry.

[45]  K. Keinänen,et al.  Lipid-tagged antibodies: bacterial expression and characterization of a lipoprotein-single-chain antibody fusion protein. , 1993, Protein engineering.

[46]  R. Karlsson,et al.  Analysis of active antibody concentration. Separation of affinity and concentration parameters. , 1993, Journal of immunological methods.

[47]  P. Carter,et al.  Engineering antibodies for imaging and therapy. , 1997, Current opinion in biotechnology.

[48]  R. Webster,et al.  Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer. , 1997, Protein engineering.

[49]  L. Nieba,et al.  Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics. , 1996, Analytical biochemistry.

[50]  D R Burton,et al.  CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. , 1995, Journal of molecular biology.

[51]  J. Bye,et al.  Human anti‐self antibodies with high specificity from phage display libraries. , 1993, The EMBO journal.

[52]  H. Hoogenboom,et al.  Determination of active single chain antibody concentrations in crude periplasmic fractions. , 1996, Journal of immunological methods.

[53]  A. Plückthun,et al.  New protein engineering approaches to multivalent and bispecific antibody fragments. , 1997, Immunotechnology : an international journal of immunological engineering.

[54]  J S Tung,et al.  Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity. , 1996, Journal of molecular biology.

[55]  G Gregoriadis,et al.  Engineering liposomes for drug delivery: progress and problems. , 1995, Trends in biotechnology.

[56]  P. T. Jones,et al.  Isolation of high affinity human antibodies directly from large synthetic repertoires. , 1994, The EMBO journal.

[57]  J. Bye,et al.  Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. , 1996, Journal of molecular biology.

[58]  C. Devlin,et al.  Production of a paraquat-specific murine single chain Fv fragment. , 1995, Journal of biochemistry.

[59]  Andrew M. Hutchinson.  Evanescent wave biosensors , 1995, Molecular biotechnology.

[60]  R. Karlsson,et al.  Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. , 1991, BioTechniques.

[61]  A. Plückthun,et al.  Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. , 1992, Biochemistry.

[62]  A. Skerra.  Bacterial expression of immunoglobulin fragments. , 1993, Current opinion in immunology.

[63]  H R Hoogenboom,et al.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage. , 1991, Journal of molecular biology.

[64]  T. Waldmann,et al.  A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin , 1989, Nature.

[65]  T. Teeri,et al.  Properties of a single-chain antibody containing different linker peptides. , 1995, Protein engineering.

[66]  A. Kortt,et al.  Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidase. , 1996, Molecular immunology.

[67]  C. Barbas,et al.  Phage display of combinatorial antibody libraries. , 1997, Current opinion in biotechnology.

[68]  M. Little,et al.  Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion. , 1996, Protein engineering.

[69]  G. Winter,et al.  Selection of phage antibodies by binding affinity. Mimicking affinity maturation. , 1992, Journal of molecular biology.

[70]  A. Plückthun.  Antibody Engineering: Advances From the Use of Escherichia coli Expression Systems , 1991, Bio/Technology.

[71]  E. Kremmer,et al.  Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions. , 1997, BioTechniques.

[72]  M Ohlin,et al.  Selection of binders from phage displayed antibody libraries using the BIAcore biosensor. , 1996, Journal of immunological methods.

[73]  A. Kortt,et al.  Identification and minimization of nonideal binding effects in BIAcore analysis: ferritin/anti-ferritin Fab' interaction as a model system. , 1997, Analytical biochemistry.

[74]  E. Kretschmann.  Die Bestimmung optischer Konstanten von Metallen durch Anregung von Oberflächenplasmaschwingungen , 1971 .

[75]  H R Hoogenboom,et al.  Designing and optimizing library selection strategies for generating high-affinity antibodies. , 1997, Trends in biotechnology.

[76]  A. Plückthun.  Mono‐ and Bivalent Antibody Fragments Produced in Escherichia coli: Engineering, Folding and Antigen Binding , 1992, Immunological reviews.

[77]  R. Karlsson,et al.  Kinetic and Concentration Analysis Using BIA Technology , 1994 .

[78]  A. Lawson,et al.  Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3. , 1994, Protein engineering.

[79]  G. Adams,et al.  Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides. , 1995, Protein engineering.

[80]  B. Snedecor,et al.  High Level Secretion of a Humanized Bispecific Diabody from Escherichia coli , 1996, Bio/Technology.

[81]  C. Borrebaeck,et al.  Kinetic Analysis of Recombinant Antibody–Antigen Interactions: Relation Between Structural Domains and Antigen Binding , 1992, Bio/Technology.

[82]  L. Christensen.  Theoretical analysis of protein concentration determination using biosensor technology under conditions of partial mass transport limitation. , 1997, Analytical biochemistry.

[83]  R. Karlsson,et al.  Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. , 1991, Journal of immunological methods.

[84]  D. Winzor,et al.  Interpretation of deviations from pseudo-first-order kinetic behavior in the characterization of ligand binding by biosensor technology. , 1996, Analytical biochemistry.

[85]  T. Teeri,et al.  Efficient secretion of murine Fab fragments by Escherichia coli is determined by the first constant domain of the heavy chain. , 1993, Gene.

[86]  R. Schier,et al.  Efficient in vitro affinity maturation of phage antibodies using BIAcore guided selections. , 1996, Human antibodies and hybridomas.

[87]  A. Plückthun,et al.  Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen. , 1996, Journal of immunology.

[88]  B. Groner,et al.  Construction, Bacterial Expression and Characterization of a Bifunctional Single–Chain Antibody–Phosphatase Fusion Protein Targeted to the Human ERBB–2 Receptor , 1992, Bio/Technology.

[89]  John W. Park,et al.  Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. , 1997, Biochemistry.

[90]  J. Link,et al.  Screening and kinetic analysis of recombinant anti-CEA antibody fragments. , 1995, Journal of immunological methods.

[91]  R. Karlsson,et al.  Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. , 1997, Journal of immunological methods.